Literature DB >> 11834367

Function of the Yersinia effector YopJ.

Kim Orth1.   

Abstract

The Yersinia virulence factor YopJ inhibits the host immune response and induces apoptosis by blocking multiple signaling pathways, including the MAPK and NFkappaB pathways in the infected cell. YopJ is a cysteine protease that cleaves a reversible post-translational modification in the form of ubiquitin or a ubiquitin-like protein. Homologues of YopJ are expressed in animal and plant pathogens, as well as a plant symbiont, suggesting a universal mechanism of regulating or modulating a variety of signaling pathways. The ability of YopJ to block the innate immune response, its activity as a ubiquitin-like protein protease and its activity with respect to mammalian signalling pathways are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834367     DOI: 10.1016/s1369-5274(02)00283-7

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  54 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Biochemical characterization of the Yersinia YopT protease: cleavage site and recognition elements in Rho GTPases.

Authors:  Feng Shao; Panayiotis O Vacratsis; Zhaoqin Bao; Katherine E Bowers; Carol A Fierke; Jack E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

Review 3.  Bacterial inhibition of eukaryotic pro-inflammatory pathways.

Authors:  Andrew S Neish
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Unifying themes in microbial associations with animal and plant hosts described using the gene ontology.

Authors:  Trudy Torto-Alalibo; Candace W Collmer; Michelle Gwinn-Giglio; Magdalen Lindeberg; Shaowu Meng; Marcus C Chibucos; Tsai-Tien Tseng; Jane Lomax; Bryan Biehl; Amelia Ireland; David Bird; Ralph A Dean; Jeremy D Glasner; Nicole Perna; Joao C Setubal; Alan Collmer; Brett M Tyler
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

5.  The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production.

Authors:  Alayne Cuzick; Fiona R Stirling; Susan L Lindsay; Thomas J Evans
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins.

Authors:  Ruchi M Newman; Prabhakar Salunkhe; Adam Godzik; John C Reed
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  In vitro signaling by MAPK and NFkappaB pathways inhibited by Yersinia YopJ.

Authors:  Sohini Mukherjee; Kim Orth
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

8.  Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.

Authors:  Michael L Fisher; Cynthia Castillo; Joan Mecsas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

Review 9.  Translocated effectors of Yersinia.

Authors:  Hiroyuki Matsumoto; Glenn M Young
Journal:  Curr Opin Microbiol       Date:  2009-02       Impact factor: 7.934

10.  Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens.

Authors:  Grégory Jubelin; Carolina Varela Chavez; Frédéric Taieb; Mark J Banfield; Ascel Samba-Louaka; Rika Nobe; Jean-Philippe Nougayrède; Robert Zumbihl; Alain Givaudan; Jean-Michel Escoubas; Eric Oswald
Journal:  PLoS One       Date:  2009-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.